12 Health Care Stocks Moving In Monday's After-Market Session

LongbridgeAII'm LongbridgeAI, I can summarize articles.

During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Circle8 Group (up 14.6%), Eocene (up 10.65%), and Baird Medical Investment (up 9.43%). Conversely, losers featured Bio Green Med Solution (down 10.9%), Kestra Medical Techs (down 9.61%), and Aclaris Therapeutics (down 9.24%), the latter following Q1 earnings release. Other decliners included Armata Pharmaceuticals and Radiopharm Theranostics.

Gainers

  • Circle8 Group (NASDAQ:CIRC) stock moved upwards by 14.6% to $0.57 during Monday's after-market session. The company's market cap stands at $50.2 million.
  • Eocene (NASDAQ:EOCN) shares rose 10.65% to $4.05. The market value of their outstanding shares is at $4.1 million.
  • Baird Medical Investment (NASDAQ:BDMD) stock moved upwards by 9.43% to $1.16. The company's market cap stands at $35.1 million.
  • Creative Medical Tech (NASDAQ:CELZ) shares rose 5.23% to $0.92. The market value of their outstanding shares is at $6.3 million.
  • Basel Medical Group (NASDAQ:BMGL) shares increased by 5.0% to $7.5.
  • iBio (NASDAQ:IBIO) shares rose 5.0% to $1.26. The market value of their outstanding shares is at $77.4 million.

Losers

  • Bio Green Med Solution (NASDAQ:BGMS) stock fell 10.9% to $0.8 during Monday's after-market session. The market value of their outstanding shares is at $5.7 million.
  • Kestra Medical Techs (NASDAQ:KMTS) stock decreased by 9.61% to $21.75. The market value of their outstanding shares is at $1.3 billion. As per the press release, Q1 earnings came out today.
  • Aclaris Therapeutics (NASDAQ:ACRS) shares fell 9.24% to $5.12. The company's market cap stands at $783.0 million.
  • Armata Pharmaceuticals (AMEX:ARMP) shares decreased by 9.19% to $5.04. The market value of their outstanding shares is at $200.0 million.
  • Radiopharm Theranostics (NASDAQ:RADX) shares declined by 7.47% to $1.86. The company's market cap stands at $28.6 million.
  • Lexaria Bioscience (NASDAQ:LEXX) shares fell 6.48% to $3.32. The company's market cap stands at $8.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Login to unlock1,226characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.